Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 10;14(2):997–1007. doi: 10.21037/jgo-22-946

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2023 Journal of Gastrointestinal Oncology. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Kaplan-Meier plots for PDAC patients gemcitabine-based and 5FU-based regimens. Kaplan-Meier plots for both PFS and OS. The red curve identifies the gem-based patients. The black curve identifies the 5FU-based patients. The x-axis represents the number of days. PFS, progression free survival; OS, overall survival; PDAC, pancreatic ductal adenocarcinoma; 5FU, 5-fluorouracil.